WB
GSK icon

West Bancorporation’s GSK GSK Stock Holding History

West Bancorporation’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-267
Closed -$15K – 301
2022
Q1 		$15K Hold
267
– – 0.01% 251
2021
Q4 		$15K Buy
+267
New +$13.9K 0.01% 242
2020
Q3 		$19K Hold
398
– – 0.02% 187
2020
Q2 		$20K Hold
398
– – 0.02% 186
2020
Q1 		$19K Hold
398
– – 0.03% 179
2019
Q4 		$23K Buy
+398
New +$22.1K 0.02% 186

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

West Bancorporation's GSK Position: Q2 2022 in Review

West Bancorporation sold out of GSK (GSK) in Q2 2022, closing a stake of 267 shares — an estimated $15K sold.

West Bancorporation first reported a position in GSK in Q4 2019 and held it in 6 quarters. The position peaked at $23K in Q4 2019. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • West Bancorporation reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • West Bancorporation sold 267 GSK shares in Q2 2022, an estimated $15K.
  • West Bancorporation first reported a position in GSK in Q4 2019 and held it in 6 quarters.
  • West Bancorporation's GSK position peaked at $23K in Q4 2019.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on West Bancorporation's 13F filing for Q2 2022, filed 15 Jul 2022.